Springboard Enterprises Announces 17 Members of Inaugural 2023 Digital Health Council

Springboard Enterprises, an organization with more than two decades of accelerating the growth of women-led start-ups has announced its inaugural 2023 Digital Health Council. The Council includes a diverse group of distinguished industry leaders from healthcare, life sciences, and technology,…

Read MoreSpringboard Enterprises Announces 17 Members of Inaugural 2023 Digital Health Council

Celiac Disease Foundation Debuts Innovative iRecruitCeliac Patient Recruitment Platform

The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, today announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions. With an established, 30-year track…

Read MoreCeliac Disease Foundation Debuts Innovative iRecruitCeliac Patient Recruitment Platform

ReAlta Life Sciences annuncia una presentazione importante al European Respiratory Society 2023 International Congress

ReAlta Life Sciences, Inc. è un’azienda di biotech clinical-stage impegnata nell’usare la potenza del sistema immunitario per contrastare e risolvere situazioni come malattie rare e malattie infiammatorie acute potenzialmente letali. L’azienda ha oggi annunciato che presenterà ulteriori dati clinica dal…

Read MoreReAlta Life Sciences annuncia una presentazione importante al European Respiratory Society 2023 International Congress

CVS Health expands access to life-saving medication naloxone by offering over-the-counter NARCAN

Following FDA approval, CVS Pharmacy® is now offering over-the-counter (OTC) naloxone, brand name NARCAN®, at more than 7,500 locations nationwide, making it easier and more discrete than ever to purchase the safe and effective antidote to opioid overdoses. What is naloxone? Available…

Read MoreCVS Health expands access to life-saving medication naloxone by offering over-the-counter NARCAN

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) administered as…

Read MorePfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences: To view and listen to the webcasts, visit our web site at www.pfizer.com Information on accessing and…

Read MorePfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences

Global Urinary Incontinence Markets, 2018-2022 & 2023-2028: Companies Innovate Advertisements to Promote Urinary Incontinence Awareness as Disposables Dominate – ResearchAndMarkets.com

The “Global Urinary Incontinence Market (2023 Edition) – Analysis By Incontinence Type (Stress, Urge, Mixed, Others), Product Type, End-user, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. The Global Urinary Incontinence Market…

Read MoreGlobal Urinary Incontinence Markets, 2018-2022 & 2023-2028: Companies Innovate Advertisements to Promote Urinary Incontinence Awareness as Disposables Dominate – ResearchAndMarkets.com

Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany

DexCom, Inc. (Nasdaq: DXCM), global manufacturer of systems for real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Real-Time Continuous Glucose Monitoring System (rt-CGM) is the first and only CGM to connect to the Omnipod 5 AID…

Read MoreDexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany

Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into definitive agreements for the purchase and sale of…

Read MoreAditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules